Swiss Re AG · SIX:SREN

Swiss Re — Investor Presentation (October 2023)

37 slides from Swiss Re's investor presentation, October 2023

  1. Slide 1: Hyperinsulinemia Consequences

    Hyperinsulinemia Consequences Benjamin Bikman, Ph.D. Professor Cell Biology and Physiology Brigham Young University

  2. Slide 2: Why does hyperinsulinemia matter?

    Why does hyperinsulinemia matter?

  3. Slide 3: What is insulin resistance?

    What is insulin resistance? Insul Insulin Some cells fail to fully respond to insulin Action Glucose Glu Insulin levels are high There is no “insulinIn resistance” some cells… without hyperinsulinemia

  4. Slide 4: Insulin Resistance

    Heart Disease Diabetes Cancer Body Fatty Fat Insulin Liver Resistance Migraines PCOS Erectile Dementia Dysfunction

  5. Slide 5: Diabetes

    Diabetes II Insulin Resistance

  6. Slide 6: Diabetes

    Diabetes II Insulin Resistance

  7. Slide 7: Diabetes

    Diabetes In true T2DM, insulin never goes to zero… Glucose Insulin is elevated Insulin is elevated Glucose is normal Glucose is elevated Insulin Insulin Type 2 Resistance Diabetes Time (years)

  8. Slide 8: Diabetes

    Diabetes Insulin ⍺ Pancreas Resistance Glucose Insulin Liver Fat Cells Muscle Insulin Type 2 Resistance Diabetes Time

  9. Slide 9: Diabetes: Muscle is the main consumer of glucose

    Diabetes Insulin Type 2 Resistance Diabetes Insulin Insulin Glucose Resistance Muscle Glucose Muscle is the main consumer of glucose PMID: 19875544

  10. Slide 10: Diabetes: Liver glycogenesis

    Diabetes Insulin Insulin Resistance Production Liver Glycogenesis of glycogen Glucose Glucose Insulin Type 2 Resistance Diabetes PMID: 20133650

  11. Slide 11: Diabetes: Glucagon, pancreas, insulin

    Diabetes Glucagon Insulin ⍺ β Pancreas PMID: 10414926

  12. Slide 12: Diabetes: Glucagon, pancreas, insulin

    Diabetes Insulin Glucagon Resistance Insulin ⍺ β Pancreas Glucose Glucose

  13. Slide 13: Diabetes: Glucagon, pancreas, insulin

    Diabetes Insulin Type 2 Resistance Diabetes Insulin Glucagon Resistance Insulin ⍺ β Pancreas Glucose Glucose

  14. Slide 14: Insulin Resistance: Hypertension and Heart Disease

    Heart Hypertension Disease Insulin Resistance

  15. Slide 15: Heart Disease

    Heart Hypertension Disease October 5, 2023 Global Effect of Modifiable Risk Factors on Cardiovascular Disease and N Engl ] Med 2023; 389:1273-1285 Mortality DOI: 10.1056/NEJMoa2206916 The Global Cardiovascular Risk Consortium* Per 5-Unit Increase Per 20-mm Hg Increase Per 38.67-mg/dl Increase in BMI

  16. Slide 16: Hypertension

    Hypertension Nervous System Activation Insulin Salt Resistance Insulin Dysfunction Sensitivity Reduced Nitric Oxide Insulin

  17. Slide 17: Insulin increases activation of the sympathetic nervous system

    Insulin increases activation of the Hypertension sympathetic nervous system Parasympathetic Sympathetic “Rest and Digest” “Fight or Flight”

  18. Slide 18: Insulin increases activation of the sympathetic nervous system

    Insulin increases activation of the Hypertension sympathetic nervous system “Fight or Flight” Normal blood Increased pressure blood pressure

  19. Slide 19: Insulin-resistant endothelial cells fail to release nitric oxide

    Hypertension Insulin-resistant endothelial cells fail to release nitric oxide Nitric oxide (NO) is a potent vasodilator Insulin sensitive NO NO Normal Increased Insulin resistant blood blood pressure pressure NO NO Blood Vessel

  20. Slide 20: Insulin increases kidney salt reabsorption

    Insulin increases kidney Hypertension salt reabsorption Kidney Sodium Sodium Sodium Normal Increased Sodium Sodium blood Sodium pressure Sodium Sodium Blood Vessel

  21. Slide 21: Insulin increases kidney salt reabsorption

    Insulin increases kidney Hypertension salt reabsorption Dietary sodium intake and mortality: the National Health and Nutrition Examination Survey (NHANES 1) “…these results do not support current recommendations for routine reduction of sodium consumption, nor do they justify advice to…decrease its

  22. Slide 22: Dietary sodium intake and cardiovascular risk: nonoverweight subjects

    Insulin increases kidney Hypertension salt reabsorption Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults ~50% ~2X ~4X Quartiles of salt consumption 1 2 3 4 Stroke mortality NS NS NS CVD mortality NS NS NS All cause mortality NS NS NS Nonoverweight subjects PMI

  23. Slide 23: Dietary sodium intake and cardiovascular risk: overweight subjects

    Insulin increases kidney Hypertension salt reabsorption Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults ~50% ~2X ~4X Quartiles of salt consumption 1 2 3 4 Stroke mortality CVD mortality All cause mortality Overweight subjects PMID: 10591385

  24. Slide 24: Nonoverweight vs overweight subjects

    Insulin increases kidney Hypertension salt reabsorption Nonoverweight subjects vs Overweight subjects

  25. Slide 25: Low-salt diet increases insulin resistance in healthy subjects

    Low-salt diet increases insulin Hypertension resistance in healthy subjects Salt Insulin Insulin Insulin Resistance What happens to insulin with salt restriction? PMID: 31357547

  26. Slide 26: Insulin Resistance: Dementia

    Insulin Resistance Dementia

  27. Slide 27: Dementia: Classic view, plaques in the brain

    Dementia Classic view: Caused by plaques in the brain Problems • Many people with plaques have normal cognition • Drugs that reduce plaques don’t help PMID: 30103319 PMID: 34103732

  28. Slide 28: Alternate view: Caused by fuel disruption

    Dementia Alternate view: Caused by fuel disruption 1 2 3 High metabolic rate = High demand for nutrients

  29. Slide 29: Alternate view: Caused by fuel disruption

    Dementia Alternate view: Caused by fuel disruption F PMID: 24598140 E

  30. Slide 30: Alternate view: Caused by fuel disruption

    Dementia Alternate view: Caused by fuel disruption Glucose Insulin Ketones

  31. Slide 31: What are ketones?

    Dementia What are ketones? Ketones Insulin Insulin Fat

  32. Slide 32: Alternate view: Caused by fuel disruption

    Dementia Alternate view: Caused by fuel disruption Glucose Insulin Ketones “Fed state” “Fasted state” PMID: 16848698

  33. Slide 33: Alternate view: Caused by fuel disruption

    Dementia Alternate view: Caused by fuel disruption No Change Glucose Insulin Alzheimer’s Ketones 13% PMID: 25147107

  34. Slide 34: Alternate view: Caused by fuel disruption

    Dementia Alternate view: Caused by fuel disruption Glucose Insulin Alzheimer’s Ketones All glucose-related Ketone-related metabolism genes metabolism genes are downregulated are normal PMID: 25147107

  35. Slide 35: Alternate view: Caused by fuel disruption

    Dementia Alternate view: Caused by fuel disruption Association between features of the insulin resistance syndrome and Alzheimer’s disease independently of apolipoprotein e4 phenotype: cross sectional population-based study Statistically significant variables that correlated with Alzheimer’s disease

  36. Slide 36: Alternate view: Caused by fuel disruption

    Dementia Alternate view: Caused by fuel disruption Glucose Insulin Alzheimer’s Ketones PMID: 25147107

  37. Slide 37: Hyperinsulinemia Consequences

    Dementia Diabetes Heart Disease Hyperinsulinemia Consequences

Swiss Re — Investor Presentation (October 2023) on 6ix